Incorporation of<i>ortho</i>-Carbaboranyl-<i>N</i><sub>ε</sub>-Modified<scp>l</scp>-Lysine into Neuropeptide Y Receptor Y<sub>1</sub>- and Y<sub>2</sub>-Selective Analogues
Verena M. Ahrens(Leipzig University), Evamarie Hey‐Hawkins(Babeș-Bolyai University), Sven Stadlbauer(Helmholtz-Zentrum Dresden-Rossendorf), René Frank(University of Leeds), Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences)
Cited by 78
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374